Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Healthtrust
Johnson and Johnson
Harvard Business School
Chubb
Citi
QuintilesIMS
US Army

Generated: August 20, 2018

DrugPatentWatch Database Preview

Corden Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for CORDEN PHARMA, and what generic and branded alternatives to CORDEN PHARMA drugs are available?

CORDEN PHARMA has five approved drugs.



Summary for Corden Pharma
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Corden Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 DISCN Yes No ➤ Sign Up ➤ Sign Up
Corden Pharma CEFZIL cefprozil TABLET;ORAL 050664-002 Dec 23, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up
Corden Pharma CEFZIL cefprozil TABLET;ORAL 050664-001 Dec 23, 1991 DISCN Yes No ➤ Sign Up ➤ Sign Up
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-001 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 DISCN Yes No ➤ Sign Up ➤ Sign Up
Corden Pharma GLEOSTINE lomustine CAPSULE;ORAL 017588-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Corden Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 4,657,927*PED ➤ Sign Up
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 4,657,927*PED ➤ Sign Up
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 4,657,927*PED ➤ Sign Up
Corden Pharma VEPESID etoposide INJECTABLE;INJECTION 018768-001 Nov 10, 1983 3,524,844 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Mallinckrodt
Boehringer Ingelheim
Fish and Richardson
UBS
Colorcon
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.